496: Reduced susceptibility of mice with CF-like lung disease to SARS-CoV-2 infection
Philip N. Hawkins(The Royal Free Hospital), Raymond J. Pickles(University of North Carolina at Chapel Hill), Ralph S. Baric(University of North Carolina at Chapel Hill), Matthew Chin Heng Chua(Yong In University), Sarah R. Leist(University of North Carolina at Chapel Hill), Wanda K. O’Neal(University of North Carolina at Chapel Hill), Rodney C. Gilmore(University of North Carolina at Chapel Hill), A.S. Volmer, Alessandra Livraghi-Butrico(University of North Carolina at Chapel Hill), Kenichi Okuda(University of North Carolina at Chapel Hill), Arnd-Oliver Schäfer, Richard C. Boucher(University of North Carolina at Chapel Hill)
Cited by 0
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
|Nature Communications|2020|1.8k